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The myogenic regulatory genes Myf5, Mrf4, Myod,
and Myogenin likely arose by gene duplications
during evolution, presumably to address the more
demanding requirements of the vertebrate body
plan. Two cell lineages were proposed to be regu-
lated independently by Myf5 andMyod to safeguard
against tissue failure. Here we report severe muscle
loss following ablation of Myf5-expressing cells. Us-
ing both lineage-specific and ubiquitous reporter al-
leles, we show that the remainingmuscles inMyf5Cre-
DTA embryos arise mainly from Myf5+ escaper cells.
Elimination of Myf5Cre-DTA cells on a Myod null
background did not result in the total absence of
skeletal muscles, as would be expected if a Myod+/
Myf5-independent cell population played a major
role in this scenario. Therefore, these observations
are incompatible with a previously proposed func-
tional two-lineage model. These findings will have
an impact on the interpretation of phenotypes ob-
tained using similar strategies in other tissues.
INTRODUCTION
Gene duplications of critical regulatory genes during evolution
likely arose to assure the establishment and diversification of
tissues as well as survival of the organism in detrimental condi-
tions. Studies in skeletal myogenesis have provided insights
into this design where the three cell fate determinants Myf5,
Myod, and Mrf4 can each autonomously govern myogenic
cell identity. Genetic studies in mice where all three genes are
compromised in function showed that myoblasts and differenti-
ated cells fail to develop (Kassar-Duchossoy et al., 2004; Rud-
nicki et al., 1992). Mice mutant for the fourth member of this
bHLH family, Myogenin, exhibit major differentiation deficits
(Tajbakhsh and Buckingham, 2000). The requirement for several
cell fate regulators is intriguing, and can be explained in part by
their distinct temporal and spatial patterns of activation during
myogenic lineage progression (Cossu et al., 1996; Goldhamer654 Developmental Cell 31, 654–667, December 8, 2014 ª2014 Elsevet al., 1995; Ott et al., 1991; Sassoon et al., 1989; Tajbakhsh
and Buckingham, 2000; Tajbakhsh et al., 1997). For example,
during development, Myf5 expression is highest in the embry-
onic phase, and it is downregulated during differentiation,
whereas Myod is expressed in both embryonic and fetal myo-
blasts and myofibers (Murphy and Kardon, 2011; Tajbakhsh
and Buckingham, 2000). In addition, while loss of function of
the major myogenic determinants Myf5 or Myod results in skel-
etal myogenesis in virtually all anatomical locations (Braun et al.,
1992; Kablar et al., 1997; Rudnicki et al., 1992; Tajbakhsh et al.,
1997), fetal myogenesis fails in Myf5:Myod double mutants
(Kassar-Duchossoy et al., 2004), demonstrating that these fac-
tors can functionally compensate for each other to a large
extent.
An unresolved question for many tissues, including skeletal
muscle, is whether different fate determinants act within a single,
or in distinct cell lineages (Figure 1A). For example, Neurogenin1
and Neurogenin2, bHLH genes that act in the nervous system,
were reported to govern distinct sensory cell populations in the
chick and mouse (Frank and Sanes, 1991; Ma et al., 1999). Simi-
larly, studies in skeletal myogenesis lead to the proposal that in-
dependent progenitor cell lineages functionally incorporate
either of the two major regulators, Myf5 or Myod, thereby
providing a failsafe mechanism during tissuegenesis (Figure 1A).
Specifically, ablation of Myf5-expressing cells in an in vitro ES
cell differentiation model (Braun and Arnold, 1996), and genetic
ablation studies in mice using a conditionally activated diph-
theria toxin gene (Gensch et al., 2008; Haldar et al., 2008) were
found to be compatible with myogenesis. A pool of Myod+ pro-
genitors that did not express Myf5 by lineage tracing criteria
was proposed to compensate for this loss in cranial and somitic
mesoderm-derived muscles. These observations could there-
fore explain in part the requirement for several cell fate determi-
nants and suggest that during evolution, duplications in
myogenic regulators (Atchley et al., 1994; Zhao et al., 2014)
might have correlated with a duplication of the respective pro-
genitor cell populations.
A two-lineage model is difficult to reconcile with a recent
report showing that DTA-mediated ablation ofMyod-expressing
cells results in complete loss of muscle at all anatomical loca-
tions (Wood et al., 2013). However, because this result does
not formally exclude the possibility of a Myod+/Myf5-inde-
pendent lineage, resolving these progenitor cell relationships isier Inc.
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during muscle ontology. Furthermore, this information will affect
the interpretation of adult muscle stem cell heterogeneity, and
phenotypes of mutants that affect this cell population (Gu¨nther
et al., 2013; Kuang et al., 2007; von Maltzahn et al., 2013).
Although both somitic and cranial mesoderm-derivedmuscles
have a critical requirement for the three myogenic determination
genes, the use of distinct upstream gene regulatory networks in
founder stem cells (Pax3 in trunk and limbs; Tbx1 and Pitx2 in
cranial mesoderm; Harel et al., 2009; Kelly, 2013; Sambasivan
et al., 2009, 2011) raises the possibility that local progenitor
cell lineages might also be diverse. Given our previous genetic
studies defining distinct gene regulatory networks in cranial-
and somite-derived muscles (Sambasivan et al., 2009), we orig-
inally performed Myf5Cre-driven cell ablation to examine cranial
muscle progenitor fates. Unexpectedly, we found severe loss
of muscle not only in the head, but also in major muscle groups
throughout the organism, implying that if a Myod+/Myf5-inde-
pendent population was present, it did not functionally compen-
sate as reported previously (Gensch et al., 2008; Haldar et al.,
2008). By tracing Myf5 progenitors following cell ablation with
a number of sensitive reporters, we demonstrate that 100%
elimination of Myf5-expressing cells cannot be achieved, and
instead we propose that Myf5+ escaper cells masquerade as
an independent Myod+ population. Together with the data ob-
tained in a Myod null background, we propose that if a Myod+/
Myf5-independent population exists, it is not functionally robust,
and thus, not compatible with a two lineage model.
RESULTS
Severe Loss of Muscle inMyf5Cre-DTA Mice
Previous studies used two differentMyf5Cre alleles (Haldar et al.,
2007; Tallquist et al., 2000) and two R26DTA mice (one with an
attenuated DTA; Brockschnieder et al., 2004; Wu et al., 2006)
to ablate Myf5-expressing cells (Gensch et al., 2008; Haldar
et al., 2008). Skeletal muscles were reported to be initially lacking
in the embryo, but this phenotype was rescued and muscles
were virtually normal in the fetus. Because the focus of those
studies was largely trunk and limb muscles with limited attention
to cranial muscles, we assessed the progenitor cell relationships
in the head in more detail, where distinct gene regulatory net-
works initiate myogenesis. We used the same Myf5Cre alleles
(Myf5CreCAP and Myf5CreSOR; Haldar et al., 2007; Tallquist et al.,
2000) crossedwithR26DTAmice in which cell deathwas reported
to occur in less than 24 hr after recombination (Ivanova et al.,
2005); referred to here as: Myf5Cre-DTA. Interestingly, the
masseter and temporalis, which are two of the major muscle
groups in the head, were entirely lacking or severely reduced in
size (Figure 1B; Figure S1A available online; and data not shown).
Extraocular and other cranial muscle phenotypes also ranged
from total absence to severe muscle loss depending on the
Myf5Cre line used (Figure 1C; Figure S1B, see below). Approxi-
mately 80% of the Myf5CreCAP/+:R26DTA/+ fetuses examined
(n = 6, embryonic day 14.5 [E14.5]; n = 13, E18.5) displayed a
cleft of the secondary palate (Figure 1B; Figures S1A and
S1C), which is consistent with a requirement for mechanical
stimuli from the adjacent masseter for proper palatogenesis
(Rot and Kablar, 2013; Rot-Nikcevic et al., 2006). Pax7+ andDevelopmMyod+ cells were absent from regions of muscle ablation, with
rare cells sparsely located among rudimentary myofibers (Fig-
ure 1B inset; Figure S1C; and data not shown). Therefore, pro-
genitor cells were also lacking in regions where muscle masses
were lost in Myf5Cre-DTA embryos.
Unexpectedly, analysis of limb and trunkmuscles at E18.5 also
revealed severe muscle loss (Figure 1D, and Figure S1D). In gen-
eral, forelimbs were more severely affected than hindlimbs (not
shown). Accordingly, 100%of theMyf5CreCAP/+:R26DTA/+ fetuses
examined showed relaxed forepaws, reduced dorsiflexion, and
lack of deltoid tuberosity (Figure 1E, n = 55; and Figure S1E, n =
7), which are phenotypes resulting from loss of muscle masses
(Blitz et al., 2009; Nowlan et al., 2010; Rot-Nikcevic et al.,
2006). We performed immunostainings for skeletal muscle-spe-
cificmyosin heavy chain (MyHC) on transverse forelimb cryosec-
tions of E18.5 control and Myf5CreCAP-DTA fetuses at different
levels along the proximo-distal axis (Figure 1D). Quantifications
of the MyHC positive area per cross-sectional area showed a
significant reduction in the total muscle area in Myf5CreCAP-DTA
fetuses (Figure 1F), in agreement with the observations in E14.5
embryos (Figures S1F andS1G). Aswith ablated cranialmuscles,
no Pax7+ cells were present at sites of muscle loss (data not
shown). Therefore, cranial- andsomite-derivedmuscleswere ab-
lated using both Cre alleles, indicating that myogenesis was not
completely rescued by a second Myf5-independent progenitor
population as previously reported.Wenote that although all mus-
cle groups were not missing in every fetus examined, collation of
data across large sample sizes (n > 24 embryos cryosectioned,
n = 55 animals total) showed that several muscle groups were
susceptible to partial or full loss, independent of body region
(Figure 1Ganddata not shown). As a striking example, theesoph-
agus, which contains a layer of circular and longitudinal skeletal
muscles, totally lacked skeletal muscles in all Myf5CreCAP-DTA
fetuses, with no rescue at any stage examined (n = 7; Figure 1H).
These observations raised questions as to why all muscles
groups were not ablated with the genetic combinations used.
We therefore performed combinations of expression analysis
and independent genetic validation experiments to address this
point and reconcile our results with those of previous reports
where muscles were reported to be virtually normal in Myf5Cre-
DTA fetuses (Gensch et al., 2008; Haldar et al., 2008).
Incomplete Ablation ofMyf5-Expressing Cells in
Myf5Cre-DTA Embryos
To examine the efficiency of DTA-mediated ablation ofMyf5-ex-
pressing cells and the efficacy of the Cre-expressing Myf5
alleles, we generatedMyf5nlacZ/Cre:R26DTA compound heterozy-
gous embryos. Myf5nlacZ embryos provide the advantage of us-
ing the more sensitive b-gal activity to report Myf5 expression
independently of Cre activity. In addition, persistence of b-gal
activity can be used as a lineage tracer at later stages to mark
cells that had historically experienced Myf5 expression in the
progenitor state independent of contemporary Myf5 protein
expression (Cossu et al., 1996; Tajbakhsh et al., 1996a; Taj-
bakhsh and Buckingham, 2000). Strikingly, we found significant
amounts of X-gal-stained Myf5nlacZ-positive cells persisting in
virtually all anatomical locations with bothCre alleles (Figure 2A).
This result was unexpected given that Myf5 expression is high-
est between E8.5 and E11.5 (Ott et al., 1991) and efficient cellental Cell 31, 654–667, December 8, 2014 ª2014 Elsevier Inc. 655
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Cell Ablations Can Confound Lineage Designationsdeath should have occurred by E12.5 if Cre had been expressed
faithfully inMyf5-positive cells. Furthermore, extensive amounts
of Myf5nlacZ-positive cells were detected in E14.5 ablated
embryos, well after reduction in the expression level of the
Myf5 gene, and after ample time for the ablation to take place
(Figure S2A).
We then used our recently reported sensitive, lineage-specific,
Pax7-driven reporter allele as a control formonitoring recombina-
tion efficiency (Pax7nGFP-stop-nlacZ hereafter called Pax7GPL; Sam-
basivan et al., 2013). Given that Pax7 is expressed in skeletal
muscle stem/progenitor cells, accessibility of this locus to Cre-
mediated recombination allows higher sensitivity for tracking
cellswithin themuscle lineage (Relaix andZammit, 2012; Samba-
sivan et al., 2013). We first tested if the Pax7GPL reporter is an
appropriate reporter for these studies. We compared the recom-
bination efficiency of Pax7GPL and R26mTmG reporters in cells
enzymatically isolated from limbs and trunks of Myf5CreCAP/+::
Pax7GPL/+::R26 mTmG/+ E13.5 and E18.5 embryos (Figures S2B
and S2C). Immunostaining with anti-Pax7, anti-GFP, and anti-
b-gal antibodies showed that more than 95%of trunk Pax7+ cells
recombined the Pax7GPL reporter by E13.5 (Figure S2B). Recom-
bination of the ubiquitous R26mTmG reporter followed the same
trend but appeared somewhat less efficient. Similar results
were obtained when scoring b-gal+ and/or GFP+ cells over the
total number of trunk Myod+ cells, on limb cell preparations (Fig-
ureS2C) andonE12.5 andE14.5 cryosections fromMyf5CreCAP/+:
Pax7GPL/+ embryos (Figures S2D and S2E; data not shown).
Together, these observations show not only that the Pax7GPL re-
porter could be used as a faithful reporter for our cell ablation
studies, but also that virtually all Pax7+ and Myod+ progenitor
cells have been primed by Myf5 by the end of the embryonic
phase. This is in agreement with previous reports, demonstrating
that the majority of satellite cell founders are primed by Mrf4
(Sambasivan et al., 2013) and Myod (Kanisicak et al., 2009) pre-
natally. Given this condition, we expect that the Myf5Cre-DTA
ablation should report in a similarmanner, i.e., that the entire pop-
ulation should be ablated.Figure 1. Severe Loss of Muscle in Myf5Cre-DTA Fetuses
(A) Schemes illustrating lineage progression during myogenesis. The bottom line d
either in a single (serial model) or in distinct (parallel model) progenitor cell popu
(B) Masseter muscle was ablated using two Myf5Cre alleles (CAP, n = 13; SOR, n
E18.5 coronal head cryosections. Higher magnification images of masseter regio
areas lackingmuscle. Asterisks highlight the presence of cleft palate. Dotted lines
muscle; F, facial muscle.
(C) Whole-mount MyHC immunostaining of E18.5 eyeballs as in scheme. Extrao
eyeballs assessed) or can be completely missing (Myf5CreSOR/+:R26DTA/+ ; n = 7, 1
rectus; LR, lateral rectus; MR, medial rectus; IR, inferior rectus; IO, inferior obliq
(D) Anti-MyHC staining of E18.5 fetal limbs showing severe reduction in size and
Sections at different levels of the proximo-distal axis of the forelimb zeugopod are
trap antibody).
(E) Macroscopic views of E18.5Myf5CreCAP/+:R26DTA/+ and control fetuses. Note
relaxed forepads and reduced dorsiflexion (arrowheads) observed in 100% of M
(F) Quantification of the total myogenic zone (MyHC+ staining/cross-sectional ar
controls (Myf5CreCAP/+ and R26DTA/+; n = 3) and Myf5CreCAP/+:R26DTA/+ (n = 4) fet
forelimb muscle mass in Myf5Cre-DTA fetuses.
(G) Table summarizing muscle phenotypes with two Myf5Cre alleles in Myf5Cre
Extraocular muscles belong to different embryo sets because whole-mount imm
(H) Anti-MyHC (green) and anti-Pax7 (red) immunostaining on transverse trunk cr
Myf5CreCAP/+:R26DTA/+ fetuses (n = 7) at E18.5. The esophagus (E) is delineated wi
Scale bars in (B) represent 500 mm, high power 25 mm; (C), 200 mm; (D), 500 mm;
DevelopmAnalysis of Myf5Cre/+::Pax7GPL/+::R26DTA/+ fetuses using both
Cre drivers (Myf5CreCAP and Myf5CreSOR) at E14.5 and E17.5
showed that in cranial and somitic muscles, massive amounts
of b-gal-expressing cells remained (Figure 2B; Figures S2F–
S2H). Therefore,Myf5Cremediated recombination of thePax7GPL
locus occurred, but these b-gal+ cells were not eliminated by
the DTA. In addition, these experiments using the Myf5nlacZ
and Pax7GPL reporters showed severe loss of muscle following
ablation of Myf5-expressing cells, similar to the data in Figure 1
in the absence of any reporter. One issue using this ablation
strategy concerns the timing of Myf5-expression and the time
required for DTA to kill these cells. We note that with both of
these reporters, X-gal+ nuclei were observed within surviving
myofibers in all body locations (Figure S2F and data not shown).
Because Myf5 is not expressed in myofibers (Gayraud-Morel
et al., 2012; Ott et al., 1991; Tajbakhsh and Buckingham,
2000), and in accordance with the persistence of these X-gal-
stained muscles in the fetus, we expect that the muscles that
were derived from Myf5-expressing cells would no longer be
ablated.
Despite extensive studies with both Myf5 and Pax7, haploin-
sufficiency has not been reported for these genes during prena-
tal myogenesis (Relaix and Zammit, 2012; Shi and Garry, 2006;
Tajbakhsh and Buckingham, 2000; Yin et al., 2013). Neverthe-
less, to circumvent an unanticipated haploinsufficiency issue
entirely, in particular in the context of cell ablation, we performed
complementary experiments using whole-mount MyHC stain-
ings in the absence of reporters (Figure 2C). These stainings
gave the same results as quantifications on tissue sections (Fig-
ure 1D), namely severe loss or reduction in muscles in Myf5Cre-
DTA fetuses. Higher variation between individuals and higher
amounts of muscle remained with Myf5CreSOR, which is likely
due to higher numbers of Myf5+ escapers (see Figures
S2H and S2I). Importantly, the b-gal+ cells that remained
following ablation using the Myf5nlacZ and Pax7GPL reporters
did not stain for cleaved-caspase3 at E12.5, E13.5, and E14.5,
indicating that these cells were not dying at these relatively lateepicts the two principal myogenic determination genesMyf5 andMyod acting
lations.
= 9; arrowheads). Anti-MyHC (green) and anti-Pax7 (red) immunostainings of
ns (bottom, insets) indicate absence of Pax7+ muscle stem/progenitor cells in
delimit masseter from facial muscles. M,masseter; T, tongue; EOM, extraocular
cular muscles are generally reduced in size (Myf5CreCAP/+:R26DTA/+ ; n = 9, 18
4 eyeballs assessed). SO, superior oblique; LP, levator palpebrae; SR, superior
ue; RB, retractor bulbi.
missing muscle masses (arrowheads) inMyf5CreCAP/+:R26DTA/+ fetuses (n = 4).
depicted as L1, L2, and L3 (see Figure S1E). R, radius, U, ulna (bones frequently
that mutant fetus is smaller with an abnormal posture. Lower images highlight
yf5CreCAP/+:R26DTA/+ fetuses (n = 55).
ea, mean ± SEM) at three different levels (L1, L2, L3) in the forelimbs of E18.5
uses. Right and left limbs were scored for each animal. Note severe deficit in
-DTA E18.5 embryos; n values are shown on top. L, left; R, right muscles.
unostainings were used for comparison.
yosections reveal complete ablation of the skeletal muscle of the esophagus in
th a dotted line. Adjacent neck muscles are not ablated inMyf5Cre-DTA fetuses.
and (H), 50 mm. See also Figure S1.
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Figure 2. Lineage-Specific and Ubiquitous Reporters Reveal Failure to Ablate Myf5-Expressing Cells in Myf5Cre-DTA Embryos
(A) X-gal stained E12.5Myf5nlacZ/+:R26DTA/+ andMyf5nlacZ/Cre:R26DTA/+ embryos. b-gal+ cells persist inMyf5nlacZ/Cre:R26DTA/+ embryos, indicating failure to ablate
allMyf5-expressing cells. Upper images show patterning of cranial muscle anlagen (Extraocular [EOM] and pharyngeal arch [PA] muscles). Note that PA muscle
anlagen is severely ablated in Myf5CreCAP embryos (white arrowhead, middle) (n = 4) whereas ablation is less severe in Myf5CreSOR embryos (n = 3) (black
(legend continued on next page)
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Cell Ablations Can Confound Lineage Designationsstages (Figure 2D; Figure S2J—control for staining; and data not
shown).
To confirm these findings, we combined Myf5CreCAP:R26DTA
with another commonly used lineage reporter that is expressed
ubiquitously. Ai9 is a universal Rosa26-derived reporter line in
which the strong CAG promoter drives conditional expression
of tdTomato (Madisen et al., 2010). In agreement with our results
obtained using bothMyf5nlacZ and Pax7GPL reporters, remaining
nonablated tdTomato+ cells were found in E14.5 Myf5CreCAP/+::
R26DTA/+::R26tdTOM/+ fetuses in MyHC+ regions of the limb (Fig-
ure 2E) and trunk (data not shown).
Taken together, these results demonstrate the existence of
nonparallel recombination between two Rosa-based reporters
(R26DTA and R26tdTOM) as well as Rosa-based and lineage-spe-
cific reporters (R26DTA and Pax7GPL) within genetically identical
cells. Therefore, the data clearly point to the presence of a
significant population of Myf5-derived nonablated cells contrib-
uting to the muscles remaining in Myf5Cre-DTA embryos and
fetuses.
Extensive Contribution ofMyf5-Derived Myogenic Cells
to Myogenesis in Myf5Cre-DTA Embryos
Having established thatMyf5-derived nonablated cells remain in
theMyf5Cre-DTA embryos, we next assessed the contribution of
the presumedMyod+/Myf5-independent cells. For a two-lineage
model to be valid as reported, all remaining Myod-expressing
cells in Myf5Cre-DTA embryos should be reporter-negative
(not Myf5-derived). Quantifications on Myf5Cre/+::Pax7GPL/+::
R26DTA/+ embryos showed b-gal Myod+ cells interspersed
with b-gal+ Myod+ cells (Figure 3A). This result suggests that a
presumed Myod+/Myf5-independent cell population (based on
reporter-negativity) and nonkilled Myod+/Myf5-derived cells
contribute to muscle rescue inMyf5Cre-DTA embryos. To assess
the relative contribution of each subpopulation, we examined the
proliferative status of b-gal and/or Myod-expressing cells with
EdU labeling (4–5 hr pulse) in the trunk muscles ofMyf5CreCAP/+::
Pax7GPL/+::R26DTA/+ embryos at different developmental stages
(Figures 3A and 3B).
InMyf5Cre-DTA embryos at E12.5, 29% of the total Myod+ cell
population was positive for the reporter (b-gal+, nonablated,
Myf5-derived), and 70% of these cells were found to be prolifer-
ating (EdU+). The b-gal Myod+ cells, which also likely includes
Pax3+ Pax7 progenitor-derived cells and potentially, the pre-
sumed Myf5-independent pool, represented a major fractionarrowhead, right). Lower images show variation in the pattern and severity of som
IC; forelimb, FL). Myf5nlacZ/CreSOR:R26DTA/+ genetic combination is null for Myf5,
(B) Whole-mount macroscopic analysis of representative muscle groups in Myf5
stained with X-gal. Note that in the latter, major cranial and somitic muscle gro
parietal; P, pectoralis major; Ta, tibialis anterior; V, vastus; SpD, spinodeltoid; Tb
extensor digitorum communis; Edl, extensor digitorum longus.
(C) Lateral views of forelimbs fromMyf5CreCAP/+ andMyf5CreCAP/+:R26DTA/+ E17.5 f
chain (MyHC-AP, alkaline phosphatase). Dotted lines delineate individual forelim
missing muscles. Asterisks indicate endogenous alkaline phosphatase activity in
(D) Immunostainings on trunk sections of E12.5 Myf5nlacZ/+:R26DTA/+ and Myf5
Myf5CreCAP/+::R26DTA/+::Pax7GPL/+ embryos (n = 2) with anti-b-gal (cyan) and antic
not dying in Myf5Cre-DTA embryos.
(E) Immunostainings of E14.5 forelimb sections ofMyf5CreCAP/+:R26tdTOM/+ andM
(red) antibodies. Note that Myf5-derived RFP+ cells remain in Myf5Cre-DTA embr
Scale bars in (A) represent 200 mm; (B) and (C), 100 mm; (D), 25 mm; and (E), 200
Developm(71%) of the total Myod+ cells, yet only 30% of these cells
were proliferating (Figure 3B; p values on Figure S3A). We note
here that a major fraction of b-gal Myod+ cells were also
Myogenin+ (83% at E12.5, n = 3); therefore, differentiated and
exited the cell cycle (data not shown). By E14.5, the situation
evolved significantly. b-gal+ Myod+ cells (Myf5-derived non-
killed) expanded substantially and contributed to 50% of the to-
tal Myod+ population inMyf5Cre-DTA embryos, with half of these
cells still in proliferation (Figure 3B). Therefore, these data sug-
gest that by E14.5, two apparent subpopulations (Myf5-derived
and Myf5-independent) contribute to similar extents to muscle
rescue in Myf5Cre-DTA embryos. We note that the presumed
Myf5-independent population was designated as such based
solely on reporter negativity.
Similar results were obtained with the ubiquitous R26tdTomato
line. In this case, more than 95% of the Myod+ cells in the control
were reporter+ at E14.5 (Figures S3B and S3C). In Myf5Cre-DTA
embryos, the nonablated reporter+ cells (55%) contributed to a
similar extent as the reporter cells (45%) to muscle rescue in
the Myf5Cre-DTA embryos.
Finally, we evaluated the efficiency of rescue by examining
Pax7 expression. In E12.5 control embryos, more than 96% of
the Pax7+ cells were Pax7GPL reporter+, and 68% of these cells
were proliferating. InMyf5Cre-DTA embryos, up to 66% of the to-
tal Pax7+ cells were reporter+ (b-gal+, nonablated,Myf5-derived),
where 77% of these cells were proliferating. This indicates that a
major proportion of the proliferating Pax7+ population present in
Myf5Cre-DTA embryos were derived from nonablated Myf5-ex-
pressing cells (Figures S3D and S3E). Similar results were ob-
tained at E14.5 (data not shown).
Taken together, these results indicate that Myf5-derived non-
ablated myogenic cells (Pax7+ or Myod+) contribute as much or
more than the presumed Myf5-independent (reporter) cells to
muscle rescue in Myf5Cre-DTA embryos. As far as the contribu-
tion of reporter-negative cells is concerned, additional valida-
tions of the genetically modified mice are necessary to ascertain
their true origins. To address this point directly, we examined the
fidelity of Cre expression from theMyf5 locus as well as the effi-
cacy of DTA-mediated cell ablation.
Nonconcordance between Modified Cre Allele and
Endogenous Myf5 Expression
Although we noted a severe loss of muscle in Myf5Cre-DTA
embryos, muscles that remained were largely reporter+itic muscle ablation betweenMyf5CreCAP andMyf5CreSOR mutants (intercostal,
whereas this is not the case for Myf5nlacZ/CreCAP:R26DTA/+ (IRES-Cre).
CreCAP/+:Pax7GPL/+ and Myf5CreCAP/+::R26DTA/+::Pax7GPL/+ E17.5 fetuses (n = 3)
ups are lacking or severely reduced (arrowheads). M, masseter; T, temporo-
, triceps brachii; Ecu, extensor carpi ulnaris; Ecr, extensor carpi radialis; Edc,
etuses (n = 5) stained bywhole-mount immunohistochemistry for myosin heavy
b muscles, which are severely reduced in the mutant, and arrowheads point to
the bones, which are not covered by muscle in the mutant.
nlacZ/CreCAP:R26DTA/+ embryos (n = 3) and E14.5 Myf5CreCAP/+:Pax7GPL/+ and
leaved caspase3 (red) antibodies. Note the persistence of b-gal+ cells that are
yf5CreCAP/+:R26tdTOM/DTA embryos (n = 2) with anti-MyHC (green) and anti-RFP
yos.
mm, high power 20 mm. See also Figure S2.
ental Cell 31, 654–667, December 8, 2014 ª2014 Elsevier Inc. 659
AB
Figure 3. Contribution of Myf5-Derived Nonkilled Myogenic Cells and Putative Myf5-Independent Cells to Muscle Rescue in Myf5Cre-DTA
Embryos
(A and B) Quantitation of the percentage of proliferating cells derived fromMyf5-expressing andMyf5-independent cell populations inMyf5CreCAP/+:Pax7GPL/+ and
Myf5CreCAP/+::R26DTA/+::Pax7GPL/+ embryos at E12.5 (n = 3), E13.5 (n = 3), and E14.5 (n = 2). Between 650 and 1,400 cells were counted per genotype and per
condition.
(A) Representative picture of the immunostainings performed with anti-b-gal (red), anti-Myod (cyan) and EdU (green) staining. Note reduction in muscle masses in
the trunk of Myf5Cre-DTA embryos (left: NT, neural tube). White arrows point to Myod+ b-gal cells that are not proliferating.
(B) Histograms of control and Myf5Cre-DTA embryos show statistically significant differences in the percentage of Myod+ bgal+ EdU, Myod+ bgal EdU, and
Myod+ bgal EdU+ populations at the respective time points (mean ± SEM, p values on Figure S3A). The percentage of Myod+ bgal+ EdU+ cells (e.g., proliferating
cells derived from Myf5-lineage derived) is not statistically different between control and Myf5Cre-DTA embryos.
Scale bars in (A) represent low power 100 mm, high powers 25 mm. See also Figure S3.
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Cell Ablations Can Confound Lineage Designations(Myf5-derived), indicating that all of the Myf5-expressing cells
were not eliminated. One possibility is that the R26DTA allele
was either not recombined or expression of DTA from the R26
locus was not sufficient to ablate all of the Myf5-expressing
cells. When we investigated the recombination efficiency of the
Myf5Cre alleles by examining R26RlacZ reporter activity, signifi-
cant variations in the extent of lacZ expression were observed
between the different Cre alleles, as well as between embryos
of the same litter (Figure S4A, data not shown). Different Rosa-
based reporters are known to have variable susceptibility for
recombination (Liu et al., 2013). Nevertheless, an intrinsic recom-
bination deficiency is not likely to be the sole explanation for the
incomplete ablation in our Myf5Cre-DTA embryos because the660 Developmental Cell 31, 654–667, December 8, 2014 ª2014 Elsevsame conditional R26 promoter-driven DTA lines were effective
in killing all muscles in MyogCre:R26DTA (Gensch et al., 2008;
R26lacZ-DTA), MyodCre:R26DTA (Wood et al., 2013; R26eGFP-DTA),
and ACTA1Cre:R26DTA (data not shown; R26eGFP-DTA) genetic
combinations where the Cre driver was used with genes that
have persistent expression in the lineage.
Another possibility is that Cre levels from the Myf5 locus are
insufficient to allow complete elimination of Myf5-expressing
cells. If that were the case, one would hypothesize that cells ex-
pressing high levels of Cre are killed efficiently, thereby resulting
in severe loss of muscle; cells expressing lower levels of Cre
might not recombine the R26DTA allele and therefore not be
killed. To investigate this possibility, we examined Myf5 andier Inc.
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Cell Ablations Can Confound Lineage DesignationsCre expression with in situ hybridization (ISH). Using a 50UTR
probe for Myf5 transcripts and in accordance with the persis-
tence of Myf5-reporter+ cells noted above, significant levels of
endogenous Myf5 transcripts were observed in somites and
limbs of E10.5 Myf5Cre-DTA embryos (Figure 4A). Importantly,
Cre expression was severely reduced and constituted only a
subset of Myf5 expression pattern even in control nonablated
embryos. Expression of Myod was also reduced in Myf5Cre-
DTA embryos, indicating that DTA ablation was functional and
a high proportion of Myod-expressing cells were Myf5-derived
(Figure 4A). Because DTA is an inhibitor of translation, we per-
formed ISH at later stages to allow enough time for complete
ablation of Myf5+ cells. At E11.5, Myf5-expressing cells re-
mained using two different R26DTA ablator mouse alleles
(Brockschnieder et al., 2004; Ivanova et al., 2005), one of which
(Myf5CreSOR:R26lacZ-DTA) is the same genetic combination re-
ported previously (Gensch et al., 2008; Figures S4B and S4C).
At E13.5, the Myod ISH pattern highlighted the loss of muscle
masses in the limbs (Figures 4B and S4D) as observed above
with whole-mount immunostaining, and with the Cre-dependent
reporters. Strikingly, Myf5-expressing cells could be still de-
tected in the limbs of E13.5 Myf5CreCAP-DTA embryos, but Cre
expression was lacking (Figures 4B and S4D). In addition,
allele-specific RT-qPCR of Myf5Cre heterozygous embryos
showed a 2- to 5-fold reduction in Cre expression from the My-
f5IRES-CreCAP/+ allele compared to the unmodified Myf5 allele
(data not shown). Therefore, the genetically altered bicistronic
(IRES)-Cre allele showed reduced expression compared to the
endogenous locus.
Finally, we examined the expression of Cre and Myf5 proteins
with immunohistochemistry (Figure 4C). Myf5 and Cre were
coexpressed to a certain extent in trunk muscle masses of
E11.5 and E12.5 control embryos. At E13.5, Cre protein was
not detected in wild-type embryos in the trunk, consistent with
the downregulation of theMyf5 locus at this stage; however, cells
expressing low levels of Cre were detected in the limbs, which is
consistent with the normal developmental timing for Myf5
expression in this location (data not shown). In agreement with
the data presented above, we found that Myf5+ cells persisted
in the trunks of E11.5, E12.5, and E13.5 Myf5CreCAP/+:R26DTA/+
embryos; however, these cells did not express detectable levels
of Cre protein. This observation suggests that high Cre-express-
ing cells were ablated, whereas the remaining Myf5-expressing
cells were not. Given this finding that Cre expression is severely
downregulated in Myf5Cre-DTA embryos, one can no longer as-
sume with confidence that the reporter cells observed above
constitute a bona fide Myf5-independent lineage.
Skeletal Muscles Persist in Myf5Cre-DTA Mice
Lacking Myod
To assess directly whether the b-gal cells in the genetic lineage
tracing studies above are indeed a Myf5-independent/Myod-
derived lineage, we decided to perform the ablation of Myf5-ex-
pressing cells in a Myod null background. If two cell lineages are
indeed present during the establishment of skeletal muscles, a to-
tal absence of myogenesis should be expected in Myf5CreCAP/+::
R26DTA/+::Myod/ embryos. Strikingly,we could not detect a sta-
tistically significant difference in the amount of skeletal muscles
remaining in the limbs of E18.5 Myf5CreCAP/+:R26DTA/+ comparedDevelopmto Myf5CreCAP/+::R26DTA/+::Myod/ fetuses (Figures 5A and 5B;
n = 4). In addition, Myf5CreCAP/+::R26DTA/+::Myod/ embryos
had relaxed forepads as observed in Myf5CreCAP/+:R26DTA/+ em-
bryos (Figure S5A). Pax7+ cells were observed in remaining
muscles of Myf5CreCAP/+::R26DTA/+and Myf5CreCAP/+::R26DTA/+::
Myod/ fetuses (Figure 5A). Higher numbers of Pax7+ cells
were observed among the muscle masses of Myod/ fetuses,
with or without cell ablation, in agreement with previous analyses
of Myod null adult mice (Asakura et al., 2007; Macharia et al.,
2010; Figure 5A). Extraocular and trunkmuscleswere also present
in E13.5 and E18.5 Myf5CreCAP/+::R26DTA/+::Myod/ embryos,
which was comparable to that of Myf5CreCAP:R26DTA embryos
(Figure S5B and data not shown). These results lead us to
conclude that the presumedMyod+/Myf5-independent (reporter)
population, if real, makes a minor contribution, if any, to rescue of
muscles, and that escaper Myf5+ cells are largely responsible for
establishing myogenesis inMyf5Cre-DTA embryos.
DISCUSSION
How tissues are established from stem and progenitor cell pop-
ulations and how this ontology contributes to the adult stem cell
pool remain a major unresolved question for most tissues. The
observation that adult muscle stem cells are heterogeneous
(Kuang et al., 2007; Rocheteau et al., 2012; Shinin et al., 2006;
Tajbakhsh, 2009) raises the possibility that distinct founder cell
populations that persist during development give rise to this di-
versity. Two models for skeletal myogenesis have been pro-
posed (Figure 1A): (1) a serial lineage model in which a single
progenitor pool expresses the Mrfs subsequently within the
same lineage, and (2) a parallel lineage model in which these
genes would be expressed in distinct lineages. Based on lineage
tracing and conditional cell ablation studies in mice, Haldar and
colleagues put forth a parallel lineage model where mutually
exclusive Myf5-derived and Myod+/Myf5-independent popula-
tions exist during skeletal myogenesis. Using the same strategy,
a second report arrived to similar conclusions (Gensch et al.,
2008). Notably, Mrf4 expression was reported to be unchanged
or even reduced in Myf5Cre-DTA early and late stage embryos
(Gensch et al., 2008; Haldar et al., 2008), and this was verified
in the present study (Figures S5C and S5D), thereby ruling out
a compensatory role for this determination gene (Kassar-Duch-
ossoy et al., 2004) in the muscle rescue observed. Therefore,
the authors concluded that the Myf5-lineage is dispensable for
myogenesis as a Myod-lineage takes over when the Myf5-line-
age is eliminated. Importantly, the observation of rescue to
virtually normal myogenesis throughout the body prompted the
authors to qualify theMyod+/Myf5-independent lineage as func-
tionally relevant.
For this model to be valid, several criteria should be fulfilled.
First, achievement of 100% ablation of theMyf5 lineage is an ab-
solute requirement for proposing the existence of a second
Myf5-independent lineage. Therefore, 100% efficiency of both
the Cre driver and reporter/ablator lines must be assured. Sec-
ond, the developmental time course of expression of the gene
being evaluated should provide sufficient time for the ablation
to take place. Thus, even if the window of opportunity of the
gene is tight (e.g., gene being rapidly downregulated) there
should be no risk of incomplete kill (Figure 5C, see below).ental Cell 31, 654–667, December 8, 2014 ª2014 Elsevier Inc. 661
AB
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Figure 4. Nonconcordance of Cre Expression Compared to Endogenous Myf5 Expression
(A and B) Assessment of Cre, Myf5, and Myod transcript levels by whole mount in situ hybridization in E10.5 (A) or E13.5 (B) Myf5CreCAP/+ and
Myf5CreCAP/+:R26DTA/+ embryos.
(A) Note that in E10.5Myf5Cre-DTA embryosCre transcripts are highly reduced and only present at the level of the forelimbs and tail, whereasMyf5 transcripts are
much more prominent (black arrowheads). Myod levels are also lower than the control. The myotome is severely affected (inset).
(legend continued on next page)
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Cell Ablations Can Confound Lineage DesignationsUsing an extensive array of genetic approaches combined
with genetic ablation studies on a large cohort of embryos,
we obtained several lines of evidence that fail to support
the model of two functional separate myogenic lineages
(Myf5-derived and Myod+/Myf5-independent) that drive devel-
opmental myogenesis independently of one another. First, in
contrast with the previous report showing restoration to ‘‘virtu-
ally normal myogenesis’’ by early fetal stages following ablation
of the Myf5-expressing cell population, we observed severe
and consistent loss of skeletal muscle at different anatomical
locations when using the same genetic approaches. Second,
we show that 100% elimination of Myf5-expressing cells in
Myf5Cre-DTA embryos is not achieved with any of the reporter
mice used (one ubiquitous and two lineage specific; see below).
Furthermore, we demonstrate that the partial muscle rescue
observed in Myf5Cre-DTA embryos is contributed largely by
Myf5-derived, nonablated cells and not exclusively by a pre-
sumed Myod+/Myf5-independent (reporter) population as pre-
viously postulated by Haldar and colleagues. In addition, we
found that Cre expression from Myf5CreCAP allele is lost or
extremely reduced in Myf5Cre-DTA embryos at different devel-
opmental stages. We propose that in this context, unfaithful
Cre expression not only leads to incomplete elimination of
Myf5-expressing cells, but also results in Myf5+/Cre cells
that masquerade as the presumed ‘‘Myod+/Myf5-independent
(reporter) lineage.’’ Finally, we challenged the existence of a
Myod+/Myf5-independent cell lineage directly. We demon-
strated that ablation of Myf5+ cells on a Myod null background
did not eliminate all the skeletal muscles, which would be ex-
pected if a Myod+/Myf5-independent lineage was the sole
contributor to muscle rescue in Myf5Cre-DTA embryos. Taken
together, these results are incompatible with a second func-
tional Myod+/Myf5-independent lineage as proposed by Haldar
and colleagues (and Gensch et al., 2008), and they strongly
point to escaper Myf5+ cells as the major contributors to myo-
genesis in Myf5-ablated embryos.
Several factors might explain the different conclusions ob-
tained from our studies and those performed previously. A
possible key factor is the genetic background used for these
types of studies. Extensive literature is available on dramatically
different phenotypes obtained for genetically modifiedmice bred
on different genetic backgrounds (http://www.jaxmice.jax.org),
although phenotypes are often more severe on purebred back-
grounds, which was not the case here.
We believe that the discordance with previous reports can be
principally attributed to the inadequacies of genetically modified
mice, as we now show using an extensive array of controls.
Several studies have demonstrated incomplete recombination
with different conditional reporters due to a number of factors
such as the chromosomal location of floxed alleles, distance be-
tween loxP sites, sequences flanking the loxP sites, stochastic
epigenetic mechanisms underlying transgene variegation, and(B) Cre expression in E13.5 Myf5Cre-DTA embryos is restricted to a few cells w
reveals severe reduction of muscles and muscle loss in the forelimb (higher pow
(C) Immunostainings of trunk sections ofMyf5CreCAP/+ andMyf5CreCAP/+:R26DTA/+
anti-Cre (green) antibodies. Note that while Myf5 and Cre staining colocalize exte
persist in the absence of Cre expression above background levels in Myf5Cre-DT
Scale bars in (A) and (B) represent 200 mm and (C) represents 20 mm. See also F
Developmthe level of Cre activity per cell (Lewandoski, 2001; Long and
Rossi, 2009; Ma et al., 2008; Nagy, 2000; Sambasivan et al.,
2013; Vooijs et al., 2001). Therefore, the interpretation of ablation
studies solely based on selected reporter alleles is a high-risk
task, particularly when the requirement of 100% ablation of a
cell population is an obligate prerequisite for support of such a
model.
In this respect, several factors can influence the interpreta-
tion of the results. First, whereas the previous studies showed
loss of Cre-dependent reporter expression in Myf5Cre-DTA em-
bryos (using Z/EG and Z/AP conditional transgenic reporters;
Gensch et al., 2008; Haldar et al., 2008), their data did not
exclude the existence of Myf5+ cells in which both the reporter
and DTA allele remained unrecombined due to insufficient
levels of Cre (see below). In the present study, the introduction
of the Myf5nlacZ reporter gave us the advantage of using the
more sensitive b-gal activity to report Myf5 expression in-
dependently of Cre activity. In addition, we benefited from
the persistence of b-gal activity as a lineage tracer at later
stages to mark cells that had historically experienced Myf5
expression in progenitor cells independent of contemporary
Myf5 protein expression.
Second, it is now well established that the Z/EG and Z/AP re-
porters used in the previous studies to score ablation efficiency
have the lowest sensitivity to Cre-mediated recombination,
which is more problematic in cells with low levels of Cre activity
(Liu et al., 2013; Ma et al., 2008; data not shown). This is attrib-
uted to its high inter-loxP distance (Liu et al., 2013) and makes
it unsuitable for tracking cell ablations, especially when it is
used to demonstrate the existence of independent cell lineages.
Indeed, our comparative analysis demonstrates clearly that Z/AP
reporter sensitivity is a major issue (Figure 5D).
In the present study, we used the newer generation Rosa26-
based Ai9 line, which is considered as one, if not the most, sen-
sitive Rosa-based reporter available (Liu et al., 2013; Madisen
et al., 2010), as well as the lineage-specific Pax7GPL line as re-
porters for cell ablation. We showed that while both reporters re-
combined efficiently, the R26DTA fails to do so and therefore only
a subpopulation of myogenic cells was efficiently ablated. More-
over, using the Pax7GPL reporter, we showed that virtually all
Pax7+ and Myod+ progenitor cells are derived from Myf5-
expressing cells, and given this condition, we should expect
that the Myf5Cre-DTA ablation reports in a similar manner, i.e.,
ablates the entire population—which is clearly not the case.
These data demonstrate the existence of nonparallel recom-
bination, i.e., different activation thresholds for individual Cre-
dependent reporters, even within a same embryo, in genetically
identical cell types (Figure 5D).
Issues regarding transcriptional and posttranscriptional regu-
lation of Cre transcripts could introduce other biases in the
experimental outcome (Sambasivan et al., 2013; Tajbakhsh,
2009; and references therein). This point is particularly importanthereas Myf5 transcripts are more abundant (black arrowheads). Myod probe
er views in Figure S4D).
E11.5 (n = 2), E12.5 (n = 7), and E13.5 (n = 2) embryos with anti-Myf5 (red) and
nsively in control embryos at E11.5 and E12.5 (white arrowheads), Myf5+ cells
A embryos.
igure S4.
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Figure 5. Muscles Persist in Myf5Cre-DTA Embryos in the Absence of Myod Function
(A and B) Comparison of forelimb muscle ablation between E18.5 controls (R26DTA/+; n = 3), Myod/ (n = 3), Myf5CreCAP/+:R26DTA/+ (n = 3) and
Myf5CreCAP/+::R26DTA/+::Myod/ (n = 4) fetuses.
(A) Representative images of anti-MyHC (green) and anti-Pax7 (red) immunostainings of E18.5 transverse forelimb cryosections.
(legend continued on next page)
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Cell Ablations Can Confound Lineage Designationswith Myf5 where its regulation, and that of the adjacent Mrf4
gene, is complicated by the presence of multiple unique and
redundant modules extending over 100 kbp (reviewed in Carva-
jal and Rigby, 2010). Problems related to Cre misexpression
have been reported previously for other tissues (e.g., Christoffels
et al., 2009; Lee et al., 2013), and this is also likely to be a major
factor leading to the misinterpretation of the genetic ablation
data in the study by Haldar and colleagues. WM-ISH and protein
immunostainings performed to compare Cre and Myf5 expres-
sion gave the striking observation that Cre expression from
the Myf5CreCAP allele is lost/extremely reduced in Myf5Cre-DTA
embryos at different developmental stages. The fact that Myf5
transcript and protein expression persist inMyf5CreCAP-DTA em-
bryos is an indicator of the differential regulation/processing of
the genetically modified (IRES)-Cre allele versus endogenous
Myf5 transcripts in vivo. In addition, a recent report (Wood
et al., 2013) demonstrates a substantial reduction in the apparent
level of Myf5 expression after ablation of differentiated muscle
using ACTA1Cre. Therefore, the maintenance ofMyf5 expression
appears to depend on the muscle environment, as has been
shown for Pax7 (Kassar-Duchossoy et al., 2005). Hence, in this
context, Cre expression would be also compromised in
Myf5Cre-DTA embryos, further confounding its ability to perform
complete ablation as required by the experimental paradigm.
In addition to these limitations, the fact thatMyf5 is expressed
briefly during lineage progression and its expression levels drop
drastically from mid-embryonic development (Figure 5C) make
this an inappropriate gene to address lineage issues of this
type unless extensive analyses using reporter gene readouts
are performed concomitantly. We therefore propose that DTA-
mediated kill occurs early in development, most likely within
the initial peak of Myf5-expression, which results in complete
ablation of subsets of muscles. After this time, expression of
Cre (and thus DTA) is not sufficient to allow 100% elimination
of Myf5+ progenitors. Consequently, this results in cells that
are (1) reporter-recombined but not ablated, or (2) neither abla-
ted nor reporter-recombined; the latter standing as the pre-
sumed ‘‘Myod+/Myf5-independent lineage.’’ We speculate that
the second wave of embryogenesis in the trunk, correlating to
progenitor cells arising from the central dermomyotome in so-
mites, is less efficiently ablated likely due to the more rapid dif-
ferentiation kinetics and downregulation of Myf5 following the
onset of Myod expression (Tajbakhsh and Buckingham, 2000).
Furthermore, differentiated muscle fibers were found to be re-
porter-positive in Myf5Cre-DTA fetuses, hence derived from
Myf5-expressing nonablated progenitors. Given that Myf5 is
not expressed after differentiation, these muscles will no longer
be eliminated by the DTA. Therefore, because only a brief win-
dow of opportunity (Tajbakhsh and Buckingham, 2000) is avail-
able during lineage progression for Cre to recombine loxP sites(B) Quantification of the total myogenic zone (MyHC+ staining/cross-sectional are
(ns) differences were observed betweenMyf5CreCAP/+:R26DTA/+ andMyf5CreCAP/+
(C) Schemes indicating the limited expression window available for Myf5 globally
(D) Comparison of the sensitivities of Z/AP, Pax7GPL, and R26tdTOM repor
(Myf5CreCAP/+:R26DTA/+, lower) (n = 2–5 embryos/genotype). Transverse sectio
derived cells persist according to the Pax7GPL and R26tdTOM reporters (arrow
Myf5CreCAP/+:R26DTA/+ fetuses (black arrow). A section adjacent to the one s
identify tongue muscles. Asterisks point to endogenous AP activity from bon
Scale bars in (A) represent low power 500 mm, high power 25 mm and (D) repres
Developmfrom the generic Rosa locus (Figure 5C), it is not surprising that
a Myf5Cre-DTA ablation strategy gives misleading results. This
is not the case for Myod where expression of this gene persists
during lineage progression, even after permanent cell cycle exit
and differentiation. Consistent with this, a recent report showed
that ablation of Myod-expressing cells results in loss of myofib-
ers and myogenic progenitors (defined by Pax7 and Myf5
expression) by E12.5 (Wood et al., 2013).
In summary, the extensive genetic data that we now provide
are in discordance with the notion of a functionally significant
Myod+/Myf5-independent lineage. Determining whether rescue
of myogenesis in these embryos is driven exclusively by expan-
sion of nonkilled Myf5-derived myoblasts or also by more up-
stream Mrf- Pax7+ progenitors (as proposed by Wood et al.,
2013) will provide important insights into mechanisms set to
regulate muscle homeostasis during development. As such,
our observations alter the current view on how tissuegenesis is
coordinated between cell fate genes and progenitor cell popula-
tions during skeletal myogenesis. These findings could influence
the interpretation of other studies in which genetic cell ablation
and lineage strategies are used to assess fundamental questions
in developmental and adult stem cell biology.
EXPERIMENTAL PROCEDURES
Animal Models
Animals were handled as per European Community guidelines and protocols
were approved by the ethics committee of the Institut Pasteur (CTEA). Cre re-
combinase, reporter, and ablator mouse lines were described previously:
Myf5nlacZ (Tajbakhsh et al., 1996b),Myf5CreCAP (Haldar et al., 2008),Myf5CreSOR
(Tallquist et al., 2000), Myodm1 (Rudnicki et al., 1992), Pax7GPL (Sambasivan
et al., 2013), R26eGFP-DTA (Ivanova et al., 2005), R26lacZ-DTA (Brockschnieder
et al., 2004), R26tdTomato (Ai9; Madisen et al., 2010), R26mTmG (Muzumdar
et al., 2007), R26RlacZ (Soriano, 1999), Z/AP (Lobe et al., 1999), and Mrf4nlacZ
(Kassar-Duchossoy et al, 2004). Mice were crossed and maintained on a F1
C57/BL6:DBA2 background and genotyped by PCR. Details on mouse
crosses are provided in the Supplemental Experimental Procedures.
EdU Administration In Vivo
For proliferation experiments in vivo, 5-ethyl-20-deoxyuridine (EdU; Invitrogen
E10187) was injected intraperitoneally to pregnant females at 30 mg/g body
weight (6 mg/ml solution in 0.9% saline) twice at 5 and 2 hr before they were
killed. EdU was detected using the Click-iT EdU Cell Proliferation Assay Kit
(Life Technologies C10350) as per manufacturer’s instructions.
Antibodies
Antibodies include myosin heavy chain (MyHC; rabbit polyclonal, kindly pro-
vided by G. Cossu, 1/1,000; mouse monoclonal, DSHB, 1/30), alkaline phos-
phatase-conjugated anti-MyHC antibody (mouse monoclonal, MY32 clone;
A4335, Sigma, 1/200), Desmin (mouse monoclonal, DAKO M0760, 1/200),
Myod (mouse monoclonal, 5.8.A, Dako, M3512, 1/150), Myf5 (rabbit poly-
clonal, Santa Cruz SC-302, 1/250), Myogenin (polyclonal, Santa Cruz sc-
576, 1/100), GFP (chicken polyclonal, Abcam ab13970, 1/1,500), Pax7 (mouse
monoclonal, DSHB, 1/20), Cre (mousemonoclonal, Abcam ab24607, 1/1,000),a, mean ± SEM) at three different forelimb levels (L1, L2, and L3). No significant
:R26DTA/+:Myod/ orMyod/ and control (Myf5CreCAP/+ or R26DTA/+) fetuses.
during development and during lineage progression.
ter lines in a control (Myf5CreCAP/+, upper) and cell ablation background
ns at the level of the tongue are shown. Note that while nonablated Myf5-
heads), this is not revealed by using the Z/AP transgenic reporter mouse in
tained for AP from the Z/AP transgene was immunostained for MyHC to
es.
ents 250 mm. See also Figure S5.
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Cell Ablations Can Confound Lineage Designationsand b-galactoside (rabbit polyclonal, MP Biomedicals 08559761, 1/1,500;
chicken polyclonal, Immune Systems, CGAL-45A-Z, 1/1,000). tdTomato was
detected with Living Colors DsRed antibody (rabbit polyclonal, Clontech
632496, 1/100).
Immunofluorescence
Immunostaining on tissue sections was performed as described elsewhere
(Sambasivan et al., 2013) with modifications (see Supplemental Experimental
Procedures). Images were acquired with the following systems: a Zeiss Axio-
plan equipped with an Apotome and ZEN software (Carl Zeiss), a Leica SPE
confocal and Leica Application Suite (LAS) software or a LSM 700 laser-scan-
ning confocal microscope and ZEN software (Carl Zeiss). All images were
assembled in Adobe Photoshop and InDesign (Adobe Systems). Some images
were assembled as maximum projections derived from stacks of optical sec-
tions using ImageJ (NIH). Immunostaining on whole-mount eyeballs and limbs
was performed as described elsewhere (Gre´goire and Kmita, 2008; Jory et al.,
2009) with modifications (see Supplemental Experimental Procedures).
In Situ Hybridization and X-Gal Staining
X-gal staining and whole-mount in situ hybridization with digoxigenin-labeled
antisense mRNA probes were performed as described previously (Tajbakhsh
et al., 1997) and in the Supplemental Experimental Procedures.
Statistics
All experiments were carried out on aminimum of three embryos except where
stated otherwise. The graphs were plotted and statistical analyses were per-
formed using Graph Pad Prism and Microsoft Excel software. All data points
are presented as mean ± SEM (error bars). The Student’s t test (two-tailed, un-
paired) was applied in all cases (*p < 0.05; **p < 0.01; ***p < 0.001) except in
Figure S1G where p values were calculated by Mann-Whitney analysis.
Assessment of the MyHC+ muscle area/limb cross-sectional area was per-
formed with Fiji (NIH) software as described in the Supplemental Experimental
Procedures.
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